StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer Blockbuster Medicines & Vaccines (>$1B) by Year

Blockbuster Medicines & Vaccines (>$1B) — Combined share of Biopharma revenue (%) (%)

Pfizer Blockbuster Medicines & Vaccines (>$1B): 65.0% in FY2025, down 1.0 pts from a year earlier.

Latest, FY2025
65.0%
Period ended Dec 31, 2025
Change on a year earlier
-1.0 pts
66.0% in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Note 17 — Significant Customers & Geographic Concentration.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBlockbuster Medicines & Vaccines (>$1B) — Combined share of Biopharma revenue (%) (%)Year on yearSource
FY2025Dec 31, 202565.0%-1.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202466.0%+2.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 202364.0%-18.0 ptsForm 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 202282.0%+7.0 ptsForm 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 202175.0%+21.0 ptsForm 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 202054.0%+5.0 ptsForm 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 201949.0%+2.0 ptsForm 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 201847.0%+1.0 ptsForm 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 201746.0%+3.0 ptsForm 10-K (filed 2020-02-27) ↗
FY2016Dec 31, 201643.0%–Form 10-K (filed 2019-02-28) ↗

Cite this data

StockData. (2026). Pfizer Blockbuster Medicines & Vaccines (>$1B) (%), annual FY2016–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-blockbuster-pct

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.